CNBC - Health
Cramer: I asked some tech insiders what to buy. They surprisingly said this drug stock
7 hours ago
Amgen says drug combo slashes risk of death by 58% in patients with lung cancer7 hours ago
Doctors call Moderna, Merck's cancer vaccine data a major advancement2 days ago
Moderna shares plunge after cancer vaccine data leaks — despite positive results4 days ago
New bipartisan bill aims to speed up clinical trials for rare disease treatments4 days ago
Novo's CagriSema obesity drug shows 25% weight loss in women in analysis4 days ago
Sickle cell gene therapies offer new hope, but access remains a major challenge10 days ago
Here's our monthly update on our 32 stocks, including 2 more names to buy11 days ago
Merck CEO tells CNBC he expects cancer vaccine will get faster to make over time11 days ago
What Maven CEO Kate Ryder tells her kids every day amid AI education threat12 days ago
Walmart to cover some GLP-1s, inhalers, insulin for employees at no cost12 days ago
UnitedHealth hikes profit outlook, tops estimates as insurer manages medical costs13 days ago
Cramer: Starbucks tells me Chipotle takeover won't happen and that's good for the stock14 days ago
Jim Cramer week ahead: Bank earnings, ASML and TSMC14 days ago
For the final 10% of cystic fibrosis patients, the breakthrough still hasn't come17 days ago
Trump doesn't think Russia plague incident is bioweapon, plans Putin call Wednesday19 days ago
Trump set to talk to Russia's Putin 'very soon' about plague-related death in Siberia19 days ago
Jim Cramer says Grail can run higher as FDA decision on Galleri nears19 days ago
Russian lab worker's suspected plague death leaves experts puzzled20 days ago
Trump offers U.S. help to Russia after plague death; WHO assesses the situation as low risk20 days ago
AstraZeneca CEO says Summit Therapeutics drug could drive future cancer combos20 days ago
Russian lab worker dies amid plague reports. Here's what we know21 days ago
Russia hospitalizes almost 200 people after death from plague: Reports21 days ago
BioMarin reports five-year Pompe disease data showing durable motor function24 days ago
Why Lilly and Novo are betting on amylin to power new obesity drugs after GLP-1s24 days ago
Big Pharma's China deal spree grows with latest tie-up worth up to $7.8 billion24 days ago
De-risking rare disease drug development24 days ago
Micron drops despite 'a great quarter.' Why Cramer is sticking with the stock16 days ago
$942 million: Insurer points finger at AI as suspect hospital charges appear25 days ago
Grindr expands beyond dating with $250 million PurposeMed acquisition25 days ago
Eli Lilly says closely watched combo obesity regimen boosts weight loss in trial26 days ago
Novo's Wegovy pill improves weight loss after people switch from injections26 days ago
